ERBB2 and neoplasm: Vav-CAR mice challenged with Her2 expressing tumors were able to mount an effective anti-tumor immune response, resulting in tumor eradication and long term survival, and this was shown to be dependent on both NK cells and CD8+ T cells with an important role also shown for CD4+ T cells and macrophages.